Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy
Authors:
- 13 March 2021
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 40 (6) , 435-446
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institutes of Health
This publication has 44 references indexed in Scilit:
- Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCsJournal of Clinical Investigation, 2012
- Immune Modulation of Vascular Resident Cells by Axl Orchestrates Carotid Intima-Media ThickeningThe American Journal of Pathology, 2012
- The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapyBlood, 2011
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cellsJournal of Experimental Medicine, 2009
- The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell developmentBlood, 2009
- Divergent Role of Donor Dendritic Cells in Rejection versus Tolerance of AllograftsJournal of the American Society of Nephrology, 2009
- A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathyJournal of Experimental Medicine, 2008
- Ex Vivo-Expanded Natural CD4+CD25+ Regulatory T Cells Synergize With Host T-Cell Depletion to Promote Long-Term Survival of AllograftsAmerican Journal of Transplantation, 2008
- Heterotopic vascularized murine cardiac transplantation to study graft arteriopathyNature Protocols, 2007
- Locally acting growth factors for vascular smooth muscle cells: endogenous synthesis and release from platelets.Circulation, 1985